id	sid	tid	token	lemma	pos
cord-281397-w7ne9mj5	1	1	key	key	JJ
cord-281397-w7ne9mj5	1	2	:	:	:
cord-281397-w7ne9mj5	1	3	cord-281397-w7ne9mj5	cord-281397-w7ne9mj5	JJ
cord-281397-w7ne9mj5	1	4	authors	author	NNS
cord-281397-w7ne9mj5	1	5	:	:	:
cord-281397-w7ne9mj5	1	6	Leverenz	Leverenz	NNP
cord-281397-w7ne9mj5	1	7	,	,	,
cord-281397-w7ne9mj5	1	8	David	David	NNP
cord-281397-w7ne9mj5	1	9	L	L	NNP
cord-281397-w7ne9mj5	1	10	;	;	:
cord-281397-w7ne9mj5	1	11	Tarrant	Tarrant	NNP
cord-281397-w7ne9mj5	1	12	,	,	,
cord-281397-w7ne9mj5	1	13	Teresa	Teresa	NNP
cord-281397-w7ne9mj5	1	14	K	K	NNP
cord-281397-w7ne9mj5	2	1	title	title	NN
cord-281397-w7ne9mj5	2	2	:	:	:
cord-281397-w7ne9mj5	2	3	Is	be	VBZ
cord-281397-w7ne9mj5	2	4	the	the	DT
cord-281397-w7ne9mj5	2	5	HScore	HScore	NNP
cord-281397-w7ne9mj5	2	6	useful	useful	JJ
cord-281397-w7ne9mj5	2	7	in	in	IN
cord-281397-w7ne9mj5	2	8	COVID-19	COVID-19	NNP
cord-281397-w7ne9mj5	2	9	?	?	.
cord-281397-w7ne9mj5	3	1	date	date	NN
cord-281397-w7ne9mj5	3	2	:	:	:
cord-281397-w7ne9mj5	3	3	2020	2020	CD
cord-281397-w7ne9mj5	3	4	-	-	HYPH
cord-281397-w7ne9mj5	3	5	05	05	CD
cord-281397-w7ne9mj5	3	6	-	-	HYPH
cord-281397-w7ne9mj5	3	7	05	05	CD
cord-281397-w7ne9mj5	3	8	journal	journal	NN
cord-281397-w7ne9mj5	3	9	:	:	:
cord-281397-w7ne9mj5	4	1	Lancet	Lancet	NNP
cord-281397-w7ne9mj5	4	2	DOI	DOI	NNP
cord-281397-w7ne9mj5	4	3	:	:	:
cord-281397-w7ne9mj5	4	4	10.1016/	10.1016/	CD
cord-281397-w7ne9mj5	5	1	s0140	s0140	NNP
cord-281397-w7ne9mj5	5	2	-	-	HYPH
cord-281397-w7ne9mj5	5	3	6736(20)31057	6736(20)31057	NNP
cord-281397-w7ne9mj5	5	4	-	-	HYPH
cord-281397-w7ne9mj5	5	5	6	6	CD
cord-281397-w7ne9mj5	5	6	sha	sha	NN
cord-281397-w7ne9mj5	5	7	:	:	:
cord-281397-w7ne9mj5	6	1	61b5529ffcdf8173802b011cffb63bc4fc409ff7	61b5529ffcdf8173802b011cffb63bc4fc409ff7	CD
cord-281397-w7ne9mj5	6	2	doc_id	doc_id	CD
cord-281397-w7ne9mj5	6	3	:	:	:
cord-281397-w7ne9mj5	6	4	281397	281397	CD
cord-281397-w7ne9mj5	6	5	cord_uid	cord_uid	NNS
cord-281397-w7ne9mj5	6	6	:	:	:
cord-281397-w7ne9mj5	7	1	w7ne9mj5	w7ne9mj5	NNP
cord-281397-w7ne9mj5	7	2	nan	nan	NNP
cord-281397-w7ne9mj5	8	1	In	in	IN
cord-281397-w7ne9mj5	8	2	a	a	DT
cord-281397-w7ne9mj5	8	3	review	review	NN
cord-281397-w7ne9mj5	8	4	of	of	IN
cord-281397-w7ne9mj5	8	5	191	191	CD
cord-281397-w7ne9mj5	8	6	patients	patient	NNS
cord-281397-w7ne9mj5	8	7	with	with	IN
cord-281397-w7ne9mj5	8	8	COVID-19	COVID-19	NNP
cord-281397-w7ne9mj5	8	9	admitted	admit	VBN
cord-281397-w7ne9mj5	8	10	to	to	IN
cord-281397-w7ne9mj5	8	11	hospital	hospital	NN
cord-281397-w7ne9mj5	8	12	,	,	,
cord-281397-w7ne9mj5	8	13	3	3	CD
cord-281397-w7ne9mj5	8	14	the	the	DT
cord-281397-w7ne9mj5	8	15	IQR	IQR	NNP
cord-281397-w7ne9mj5	8	16	of	of	IN
cord-281397-w7ne9mj5	8	17	ferritin	ferritin	NN
cord-281397-w7ne9mj5	8	18	concentrations	concentration	NNS
cord-281397-w7ne9mj5	8	19	at	at	IN
cord-281397-w7ne9mj5	8	20	time	time	NN
cord-281397-w7ne9mj5	8	21	of	of	IN
cord-281397-w7ne9mj5	8	22	admission	admission	NN
cord-281397-w7ne9mj5	8	23	in	in	IN
cord-281397-w7ne9mj5	8	24	non	non	NNS
cord-281397-w7ne9mj5	8	25	-	-	NNS
cord-281397-w7ne9mj5	8	26	survivors	survivor	NNS
cord-281397-w7ne9mj5	8	27	was	be	VBD
cord-281397-w7ne9mj5	8	28	728·9	728·9	CD
cord-281397-w7ne9mj5	8	29	-	-	HYPH
cord-281397-w7ne9mj5	8	30	2000·0	2000·0	CD
cord-281397-w7ne9mj5	8	31	ng	ng	NN
cord-281397-w7ne9mj5	8	32	/	/	SYM
cord-281397-w7ne9mj5	8	33	mL	mL	NNP
cord-281397-w7ne9mj5	8	34	,	,	,
cord-281397-w7ne9mj5	8	35	and	and	CC
cord-281397-w7ne9mj5	8	36	the	the	DT
cord-281397-w7ne9mj5	8	37	median	median	JJ
cord-281397-w7ne9mj5	8	38	ferritin	ferritin	NNS
cord-281397-w7ne9mj5	8	39	did	do	VBD
cord-281397-w7ne9mj5	8	40	not	not	RB
cord-281397-w7ne9mj5	8	41	exceed	exceed	VB
cord-281397-w7ne9mj5	8	42	2000·0	2000·0	CD
cord-281397-w7ne9mj5	8	43	ng	ng	NNP
cord-281397-w7ne9mj5	8	44	/	/	SYM
cord-281397-w7ne9mj5	8	45	mL	ml	NN
cord-281397-w7ne9mj5	8	46	until	until	IN
cord-281397-w7ne9mj5	8	47	16	16	CD
cord-281397-w7ne9mj5	8	48	days	day	NNS
cord-281397-w7ne9mj5	8	49	after	after	IN
cord-281397-w7ne9mj5	8	50	symptom	symptom	NN
cord-281397-w7ne9mj5	8	51	onset	onset	NN
cord-281397-w7ne9mj5	8	52	,	,	,
cord-281397-w7ne9mj5	8	53	when	when	WRB
cord-281397-w7ne9mj5	8	54	most	most	JJS
cord-281397-w7ne9mj5	8	55	patients	patient	NNS
cord-281397-w7ne9mj5	8	56	had	have	VBD
cord-281397-w7ne9mj5	8	57	experienced	experience	VBN
cord-281397-w7ne9mj5	8	58	acute	acute	JJ
cord-281397-w7ne9mj5	8	59	respiratory	respiratory	JJ
cord-281397-w7ne9mj5	8	60	distress	distress	NN
cord-281397-w7ne9mj5	8	61	syndrome	syndrome	NN
cord-281397-w7ne9mj5	8	62	requiring	require	VBG
cord-281397-w7ne9mj5	8	63	intubation	intubation	NN
cord-281397-w7ne9mj5	8	64	.	.	.
cord-281397-w7ne9mj5	9	1	Other	other	JJ
cord-281397-w7ne9mj5	9	2	HScore	HScore	NNP
cord-281397-w7ne9mj5	9	3	criteria	criterion	NNS
cord-281397-w7ne9mj5	9	4	such	such	JJ
cord-281397-w7ne9mj5	9	5	as	as	IN
cord-281397-w7ne9mj5	9	6	hypertriglyceridaemia	hypertriglyceridaemia	NNP
cord-281397-w7ne9mj5	9	7	,	,	,
cord-281397-w7ne9mj5	9	8	splenomegaly	splenomegaly	NN
cord-281397-w7ne9mj5	9	9	,	,	,
cord-281397-w7ne9mj5	9	10	hepatomegaly	hepatomegaly	NNP
cord-281397-w7ne9mj5	9	11	,	,	,
cord-281397-w7ne9mj5	9	12	and	and	CC
cord-281397-w7ne9mj5	9	13	bone	bone	NN
cord-281397-w7ne9mj5	9	14	marrow	marrow	NN
cord-281397-w7ne9mj5	9	15	haemophagocytosis	haemophagocytosis	NNP
cord-281397-w7ne9mj5	9	16	are	be	VBP
cord-281397-w7ne9mj5	9	17	not	not	RB
cord-281397-w7ne9mj5	9	18	reported	report	VBN
cord-281397-w7ne9mj5	9	19	in	in	IN
cord-281397-w7ne9mj5	9	20	most	most	JJS
cord-281397-w7ne9mj5	9	21	cohort	cohort	NN
cord-281397-w7ne9mj5	9	22	studies	study	NNS
cord-281397-w7ne9mj5	9	23	of	of	IN
cord-281397-w7ne9mj5	9	24	COVID-19	COVID-19	NNP
cord-281397-w7ne9mj5	9	25	.	.	.
cord-281397-w7ne9mj5	10	1	Finally	finally	RB
cord-281397-w7ne9mj5	10	2	,	,	,
cord-281397-w7ne9mj5	10	3	high	high	JJ
cord-281397-w7ne9mj5	10	4	fevers	fever	NNS
cord-281397-w7ne9mj5	10	5	are	be	VBP
cord-281397-w7ne9mj5	10	6	weighted	weight	VBN
cord-281397-w7ne9mj5	10	7	heavily	heavily	RB
cord-281397-w7ne9mj5	10	8	in	in	IN
cord-281397-w7ne9mj5	10	9	the	the	DT
cord-281397-w7ne9mj5	10	10	HScore	HScore	NNP
cord-281397-w7ne9mj5	10	11	;	;	:
cord-281397-w7ne9mj5	10	12	however	however	RB
cord-281397-w7ne9mj5	10	13	,	,	,
cord-281397-w7ne9mj5	10	14	temperature	temperature	NN
cord-281397-w7ne9mj5	10	15	above	above	IN
cord-281397-w7ne9mj5	10	16	39·0	39·0	CD
cord-281397-w7ne9mj5	10	17	°	°	NN
cord-281397-w7ne9mj5	10	18	C	c	NN
cord-281397-w7ne9mj5	10	19	does	do	VBZ
cord-281397-w7ne9mj5	10	20	not	not	RB
cord-281397-w7ne9mj5	10	21	distinguish	distinguish	VB
cord-281397-w7ne9mj5	10	22	between	between	IN
cord-281397-w7ne9mj5	10	23	patients	patient	NNS
cord-281397-w7ne9mj5	10	24	with	with	IN
cord-281397-w7ne9mj5	10	25	moderate	moderate	JJ
cord-281397-w7ne9mj5	10	26	versus	versus	IN
cord-281397-w7ne9mj5	10	27	severe	severe	JJ
cord-281397-w7ne9mj5	10	28	COVID-19	covid-19	NN
cord-281397-w7ne9mj5	10	29	.	.	.
cord-281397-w7ne9mj5	10	30	4	4	CD
cord-281397-w7ne9mj5	11	1	In	in	IN
cord-281397-w7ne9mj5	11	2	summary	summary	NN
cord-281397-w7ne9mj5	11	3	,	,	,
cord-281397-w7ne9mj5	11	4	although	although	IN
cord-281397-w7ne9mj5	11	5	we	-PRON-	PRP
cord-281397-w7ne9mj5	11	6	agree	agree	VBP
cord-281397-w7ne9mj5	11	7	that	that	IN
cord-281397-w7ne9mj5	11	8	the	the	DT
cord-281397-w7ne9mj5	11	9	detection	detection	NN
cord-281397-w7ne9mj5	11	10	and	and	CC
cord-281397-w7ne9mj5	11	11	management	management	NN
cord-281397-w7ne9mj5	11	12	of	of	IN
cord-281397-w7ne9mj5	11	13	hyperinflammatory	hyperinflammatory	NNP
cord-281397-w7ne9mj5	11	14	states	state	NNS
cord-281397-w7ne9mj5	11	15	in	in	IN
cord-281397-w7ne9mj5	11	16	COVID-19	COVID-19	NNP
cord-281397-w7ne9mj5	11	17	is	be	VBZ
cord-281397-w7ne9mj5	11	18	important	important	JJ
cord-281397-w7ne9mj5	11	19	,	,	,
cord-281397-w7ne9mj5	11	20	we	-PRON-	PRP
cord-281397-w7ne9mj5	11	21	recommend	recommend	VBP
cord-281397-w7ne9mj5	11	22	against	against	IN
cord-281397-w7ne9mj5	11	23	using	use	VBG
cord-281397-w7ne9mj5	11	24	the	the	DT
cord-281397-w7ne9mj5	11	25	HScore	HScore	NNP
cord-281397-w7ne9mj5	11	26	due	due	IN
cord-281397-w7ne9mj5	11	27	to	to	IN
cord-281397-w7ne9mj5	11	28	a	a	DT
cord-281397-w7ne9mj5	11	29	potential	potential	JJ
cord-281397-w7ne9mj5	11	30	lack	lack	NN
cord-281397-w7ne9mj5	11	31	of	of	IN
cord-281397-w7ne9mj5	11	32	sensitivity	sensitivity	NN
cord-281397-w7ne9mj5	11	33	.	.	.
cord-281397-w7ne9mj5	12	1	We	-PRON-	PRP
cord-281397-w7ne9mj5	12	2	declare	declare	VBP
cord-281397-w7ne9mj5	12	3	no	no	DT
cord-281397-w7ne9mj5	12	4	competing	compete	VBG
cord-281397-w7ne9mj5	12	5	interests	interest	NNS
cord-281397-w7ne9mj5	12	6	.	.	.
cord-281397-w7ne9mj5	12	7	 	 	_SP
cord-281397-w7ne9mj5	13	1	COVID-19	covid-19	VB
cord-281397-w7ne9mj5	13	2	:	:	:
cord-281397-w7ne9mj5	13	3	consider	consider	VB
cord-281397-w7ne9mj5	13	4	cytokine	cytokine	JJ
cord-281397-w7ne9mj5	13	5	storm	storm	NN
cord-281397-w7ne9mj5	13	6	syndromes	syndrome	NNS
cord-281397-w7ne9mj5	13	7	and	and	CC
cord-281397-w7ne9mj5	13	8	immunosuppression	immunosuppression	NN
cord-281397-w7ne9mj5	13	9	Development	development	NN
cord-281397-w7ne9mj5	13	10	and	and	CC
cord-281397-w7ne9mj5	13	11	validation	validation	NN
cord-281397-w7ne9mj5	13	12	of	of	IN
cord-281397-w7ne9mj5	13	13	the	the	DT
cord-281397-w7ne9mj5	13	14	HScore	HScore	NNP
cord-281397-w7ne9mj5	13	15	,	,	,
cord-281397-w7ne9mj5	13	16	a	a	DT
cord-281397-w7ne9mj5	13	17	score	score	NN
cord-281397-w7ne9mj5	13	18	for	for	IN
cord-281397-w7ne9mj5	13	19	the	the	DT
cord-281397-w7ne9mj5	13	20	diagnosis	diagnosis	NN
cord-281397-w7ne9mj5	13	21	of	of	IN
cord-281397-w7ne9mj5	13	22	reactive	reactive	JJ
cord-281397-w7ne9mj5	13	23	hemophagocytic	hemophagocytic	JJ
cord-281397-w7ne9mj5	13	24	syndrome	syndrome	NN
cord-281397-w7ne9mj5	13	25	Clinical	Clinical	NNP
cord-281397-w7ne9mj5	13	26	course	course	NN
cord-281397-w7ne9mj5	13	27	and	and	CC
cord-281397-w7ne9mj5	13	28	risk	risk	NN
cord-281397-w7ne9mj5	13	29	factors	factor	NNS
cord-281397-w7ne9mj5	13	30	for	for	IN
cord-281397-w7ne9mj5	13	31	mortality	mortality	NN
cord-281397-w7ne9mj5	13	32	of	of	IN
cord-281397-w7ne9mj5	13	33	adult	adult	NN
cord-281397-w7ne9mj5	13	34	inpatients	inpatient	NNS
cord-281397-w7ne9mj5	13	35	with	with	IN
cord-281397-w7ne9mj5	13	36	COVID-19	COVID-19	NNP
cord-281397-w7ne9mj5	13	37	in	in	IN
cord-281397-w7ne9mj5	13	38	Wuhan	Wuhan	NNP
cord-281397-w7ne9mj5	13	39	,	,	,
cord-281397-w7ne9mj5	13	40	China	China	NNP
cord-281397-w7ne9mj5	13	41	:	:	:
cord-281397-w7ne9mj5	14	1	a	a	DT
cord-281397-w7ne9mj5	14	2	retrospective	retrospective	JJ
cord-281397-w7ne9mj5	14	3	cohort	cohort	NN
cord-281397-w7ne9mj5	14	4	study	study	NN
cord-281397-w7ne9mj5	14	5	Clinical	clinical	JJ
cord-281397-w7ne9mj5	14	6	and	and	CC
cord-281397-w7ne9mj5	14	7	immunologic	immunologic	JJ
cord-281397-w7ne9mj5	14	8	features	feature	NNS
cord-281397-w7ne9mj5	14	9	in	in	IN
cord-281397-w7ne9mj5	14	10	severe	severe	JJ
cord-281397-w7ne9mj5	14	11	and	and	CC
cord-281397-w7ne9mj5	14	12	moderate	moderate	JJ
cord-281397-w7ne9mj5	14	13	coronavirus	coronavirus	NN
cord-281397-w7ne9mj5	14	14	disease	disease	NN
cord-281397-w7ne9mj5	14	15	2019	2019	CD